期刊文献+

保乳联合前哨淋巴结活检保腋窝在早期乳腺癌治疗中的临床价值 被引量:15

下载PDF
导出
摘要 目的探讨保乳联合前哨淋巴结活检保腋窝在早期乳腺癌治疗中的临床价值。方法回顾性分析78例保乳联合前哨淋巴结活检保腋窝手术和77例传统手术在早期乳腺癌患者围术期情况,术后生活质量和美容效果,术后局部复发率,远处转移率,生存率进行回访。结果 2组手术时间、出血量、皮下积液皮癣坏死率和上肢水肿比较差异均有统计学意义(P<0.05);2组3年无瘤生存率、生存率比较差异无计学意义(P>0.05)。2组术后局部复发率远处转移率及生存率差异无统计学意义(P>0.05);保乳保腋窝组的患者乳房美容效果好,满意度高,术后并发症少,生活质量明显优于改良报治组患者。结论保乳联合前哨淋巴结活检保腋窝手术具有手术时间短,创伤小,术后恢复快,并发症少,美容效果好等特点,提高了患者的生活质量,对远期的生存率,复发率无影响。
出处 《河北医药》 CAS 2014年第6期837-838,共2页 Hebei Medical Journal
  • 相关文献

参考文献7

  • 1Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a com- parison of conservation with mastectomy in the treatment of stage Ⅰ and Ⅱ breast cancer. N Engl J Med, 1995,332:907-911.
  • 2Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conser- vation therapy: the National Cancer Institute Randomized Trial. Cancer, 2003,98:697-702.
  • 3Solin LJ, Fourquet A, McCormick B, et al. Salvage treatment for local recurrence following breast-conserving surgery and definitive ir radiation for ductal carcinoma in situ ( intraductal carcinoma) of thebreast. Int J Radiat Oneol Biol Phys,1994,30:3-9.
  • 4Komoike Y, Motomura K, Inaji H, et al. Repeat lumpectomy for patients with ipsilateral breast tumor recurrence after breast-conserving surgery. Oncology ,2003,64 : 1-6.
  • 5Pumshotham AD, Upponi S, Klevesath MB. Morbidityafter sentinel lymphnodebiopsy inprimary breast cancer: results frema randomized con- trolledtrial. J Clin Oncol,2005,23:4312-4321.
  • 6雷秋模,雷杰言,徐亮,漆幼珊.亚甲蓝示踪在乳腺癌前哨淋巴结活检中的应用价值研究[J].中国全科医学,2012,15(26):3028-3030. 被引量:10
  • 7赵晶,尉承泽.乳腺癌新辅助化疗前后前哨淋巴结活检的应用现状[J].临床误诊误治,2012,25(9):94-97. 被引量:14

二级参考文献46

  • 1Krag D N,Anderson S J,Julian T B,et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer : overall survival findings from the NSABP B-32 randomised phase 3 trial[ J]. Lancet Oncol, 2010,11 (10): 927-933.
  • 2Caudle A S,Hunt K K,Kuerer H et al. Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study ; A Practice-Changing Trial [ J]. Ann Surg Oncol, 2011,18(9) :2407-2412.
  • 3Olson JA Jr,McCall L M, Beitsch P, et al. Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes : results from American College of Surgeons Oncology Group Trials Z0010 and Z0011 [J]. J Clin Oncol, 2008,26 ( 21): 3530-3535.
  • 4Mieog J S, van der Hage J A, van de Velde C J. Neoadjuvant chemotherapy for operable breast cancer [J]. Br J Surg, 2007,94(10) :1189-1200.
  • 5Buchholz T A, Lehman C D, Harris J R, et al. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer : a National Cancer Insti-tute conference[ J]. J Clin Oncol,2008,26(5) :791-797.
  • 6Loo C E, Teertstra H J, Rodenhuis S, et al. Dynamic contrast-enhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy : initial results [ J]. AJR Am J Roentgenol, 2008,191(5):1331-1338.
  • 7Noguchi M. Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer [ J]. Eur J Surg Oncol, 2008,34(2) : 129-134.
  • 8Purushotham A D, Upponi S, Klevesath MB, et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial [ J]. J Clin Oncol, 2005,23(19):4312-4321.
  • 9Kang S H,Kang J H,Choi E A,et al. Sentinel lymph node biopsy after neoadjuvant chemotherapy [ J]. Breast Cancer, 2004,11(3) :233-241.
  • 10Chung M H,Ye W, Giuliano A E. Role for sentinel lymph node dissection in the management of large ( > or = 5 cm) invasive breast cancerf J]. Ann Surg Oncol, 2001,8(9) :688-692.

共引文献22

同被引文献84

引证文献15

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部